John Chalmers AC's Publications

About John Chalmers AC's Publications

Senior Director, Professorial Unit, The George Institute (Australia)
  • Professor of Medicine, UNSW Sydney
  • Emeritus Professor of Medicine at Flinders University and at the University of Sydney
  • FAA,
  • FAHMS,
  • FRACP
  • Routine blood pressure lowering and intensive glucose control in patients with Type 2 diabetes: the ADVANCE trial

    Expert Review of Endocrinology & Metabolism Date published:
  • Proteinuria and Stroke: A Meta-analysis of Cohort Studies

    American Journal of Kidney Diseases Date published:
  • Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes

    Journal of the American Society of Nephrology Date published:
  • ADVANCE: Blood Pressure Lowering in Diabetes

    The Journal of Clinical Hypertension Date published:
  • ADVANCE: Blood Pressure Lowering in Diabetes

    The Journal of Clinical Hypertension Date published:
  • Risks of cardiovascular disease and severe hypoglycaemia according to cognitive function in people with type 2 diabetes in ADVANCE

    Date published:
  • ASPIRIN BENEFIT INCREASES WITH DECLINING RENAL FUNCTION AMONG PEOPLE WITH HYPERTENSION

    Date published:
  • A NEW MODEL FOR PREDICTING THE RISK OF MAJOR CARDIOVASCULAR OUTCOMES IN PEOPLE WITH DIABETES

    Date published:
  • THE BENEFITS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE

    Date published:
  • RELATIONSHIP BETWEEN AMBULATORY AND CLINIC BLOOD PRESSURE: A HIGH BLOOD PRESSURE RESEARCH COUNCIL OF AUSTRALIA INITIATIVE

    Date published:
  • THE FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE HAS A GREATER EFFECT ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND ALBUMINURIA

    Date published:
  • THE EFFECTS OF A FIXED COMBINATION OF PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS ACCORDING TO BASELINE CARDIOVASCULAR RISK IN THE ADVANCE TRIAL

    Date published:
  • EFFECTS OF BLOOD PRESSURE LEVELS AT PRESENTATION AND ACHIEVED IN THE FIRST 24 HOURS ON HAEMATOMA GROWTH IN ACUTE INTRACEREBRAL HAEMORRHAGE: THE INTERACT TRIAL

    Date published:
  • Cardiovascular Risk in Type 2 Diabetes - Reflecting on the ADVANCE Study

    European Endocrinology Date published:
  • Cardiovascular Risk in Type 2 Diabetes - Reflecting on the ADVANCE Study

    US Endocrinology Date published:
  • Prescribing Of Secondary Prevention Measures In Australian General Practice Is Lower In Patients Following A Stroke Compared To Those With A Previous Myocardial Infarction

    Cerebrovascular Diseases Date published: